R53C (p.Arg53Cys) variant of PAH (Phenylalanine-4-hydroxylase)

R53C (p.Arg53Cys) in PAH (Phenylalanine-4-hydroxylase) is a missense change. Clinical records from EBI and UniProt describe it as likely pathogenic in the context of in PAH deficiency. The available variant effect predictions contribute to a CATVariant prioritization score of 0.73 / 1. The record also includes population frequency data, published literature, and structural context.

R53C (p.Arg53Cys) variant details